Hyperfine, Inc. (HYPR) 10-Year Financial Performance & Capital Metrics

HYPR • • Industrial / General

HealthcareMedical DevicesDiagnostic & Imaging EquipmentMedical Imaging Systems

AboutHyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.Show more

Revenue $13M +16.8%
EBITDA -$42M +10.3%
Net Income -$41M +8.0%
EPS (Diluted) -0.56 +9.7%
Gross Margin 45.7% +6.0%
EBITDA Margin -327.5% +23.2%
Operating Margin -335.33% +23.1%
Net Margin -315.9% +21.2%
ROE -61.03% -43.6%
ROIC -307.79% +36.5%
Debt/Equity 0.01 +150.2%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free

✗Weaknesses

✗Weak Piotroski F-Score: 3/9
✗Negative free cash flow
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y105.01%

TTM-20.1%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM2.35%

EPS CAGR

10Y-

5Y-

3Y-

TTM8.77%

ROCE

10Y Avg-54.34%

5Y Avg-51.33%

3Y Avg-52.26%

Latest-63.75%

Peer Comparison

Medical Imaging Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
IRMDIRadimed Corporation	1.3B	102.57	68.38	11.71%	26.31%	21.54%	1.35%	0.00
BRKRBruker Corporation	7.52B	49.46	65.08	13.56%	-0.61%	-0.84%	1.81%	1.24
STESTERIS plc	26.33B	268.26	43.27	6.24%	12.07%	9.8%	2.95%	0.33
FONRFONAR Corporation	114.98M	18.64	15.15	1.43%	7.08%	4.62%	6.48%	0.24
HYPRHyperfine, Inc.	100.18M	1.22	-2.18	16.84%	-378.17%	-149.05%		0.01
PACBPacific Biosciences of California, Inc.	709.48M	2.35	-2.20	-23.19%	-325.8%	-13.95%		1.33
IRIXIRIDEX Corporation	23.21M	1.35	-2.50	-6.17%	-10.04%	-108.67%		2.21
MASS908 Devices Inc.	199.79M	5.52	-2.60	18.72%	-7.17%	-3.03%		0.06

Profit & Loss

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	0	294K	1.5M	6.81M	11.03M	12.89M
Revenue Growth %	-	-	4.09%	3.55%	0.62%	0.17%
Cost of Goods Sold+	0	771K	2.66M	5.91M	6.28M	7M
COGS % of Revenue	-	2.62%	1.78%	0.87%	0.57%	0.54%
Gross Profit+	0	-477K	-1.17M	907K	4.76M	5.89M
Gross Margin %	-	-1.62%	-0.78%	0.13%	0.43%	0.46%
Gross Profit Growth %	-	-	-1.45%	1.78%	4.24%	0.24%
Operating Expenses+	19.97M	23.01M	63.7M	74.78M	52.87M	49.12M
OpEx % of Revenue	-	78.28%	42.58%	10.97%	4.79%	3.81%
Selling, General & Admin	6.58M	8.42M	37.86M	46.63M	30.38M	26.62M
SG&A % of Revenue	-	28.64%	25.31%	6.84%	2.75%	2.06%
Research & Development	13.39M	14.59M	25.84M	28.16M	22.49M	22.5M
R&D % of Revenue	-	49.64%	17.27%	4.13%	2.04%	1.75%
Other Operating Expenses	0	0	0	0	0	0
Operating Income+	-19.97M	-23.49M	-64.87M	-73.87M	-48.12M	-43.22M
Operating Margin %	-	-79.9%	-43.36%	-10.84%	-4.36%	-3.35%
Operating Income Growth %	-	-0.18%	-1.76%	-0.14%	0.35%	0.1%
EBITDA+	-19.83M	-23.2M	-64.14M	-72.86M	-47.06M	-42.22M
EBITDA Margin %	-	-78.92%	-42.88%	-10.69%	-4.27%	-3.28%
EBITDA Growth %	-	-0.17%	-1.76%	-0.14%	0.35%	0.1%
D&A (Non-Cash Add-back)	141K	289K	726K	1.01M	1.05M	1.01M
EBIT	-19.97M	-23.49M	-64.87M	-73.87M	-48.12M	-43.22M
Net Interest Income+	630K	70K	18K	761K	3.84M	2.49M
Interest Income	630K	70K	18K	761K	3.84M	2.49M
Interest Expense	0	0	0	0	0	0
Other Income/Expense	553K	64K	17K	710K	3.88M	2.5M
Pretax Income+	-19.41M	-23.43M	-64.85M	-73.16M	-44.24M	-40.72M
Pretax Margin %	-	-79.68%	-43.35%	-10.74%	-4.01%	-3.16%
Income Tax+	0	0	0	0	0	0
Effective Tax Rate %	0.97%	1%	1%	1%	1%	1%
Net Income+	-18.79M	-23.36M	-64.83M	-73.16M	-44.24M	-40.72M
Net Margin %	-	-79.45%	-43.34%	-10.74%	-4.01%	-3.16%
Net Income Growth %	-	-0.24%	-1.78%	-0.13%	0.4%	0.08%
Net Income (Continuing)	-19.41M	-23.43M	-64.85M	-73.16M	-44.24M	-40.72M
Discontinued Operations	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0
EPS (Diluted)+	-4.06	-0.93	-0.92	-1.04	-0.62	-0.56
EPS Growth %	-	0.77%	0.01%	-0.13%	0.4%	0.1%
EPS (Basic)	-4.06	-0.93	-0.92	-1.04	-0.62	-0.56
Diluted Shares Outstanding	4.62M	25.2M	70.33M	70.45M	71.32M	72.41M
Basic Shares Outstanding	4.62M	25.2M	70.33M	70.45M	71.32M	72.41M
Dividend Payout Ratio	-	-	-	-	-	-

Balance Sheet

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	27.96M	68.33M	197.49M	128.66M	88.91M	53.71M
Cash & Short-Term Investments	26.44M	62.68M	188.5M	118.24M	75.18M	37.65M
Cash Only	26.44M	62.68M	188.5M	118.24M	75.18M	37.65M
Short-Term Investments	0	0	0	0	0	0
Accounts Receivable	0	174K	644K	3.13M	4.13M	8.3M
Days Sales Outstanding	-	216.02	157.13	167.66	136.68	235.17
Inventory	0	1.72M	4.31M	4.62M	6.58M	5.83M
Days Inventory Outstanding	-	813.32	590.74	285.6	382.86	304.14
Other Current Assets	683K	3.54M	2.87M	2.67M	3.01M	1.93M
Total Non-Current Assets+	2.61M	3.19M	4.99M	5.39M	5.29M	5.19M
Property, Plant & Equipment	489K	1.9M	3.75M	3.25M	3M	3.12M
Fixed Asset Turnover	-	0.15x	0.40x	2.10x	3.68x	4.13x
Goodwill	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0
Long-Term Investments	0	0	0	744K	0	825K
Other Non-Current Assets	2.12M	1.29M	1.24M	1.4M	2.29M	1.24M
Total Assets+	30.57M	71.53M	202.47M	134.05M	94.2M	58.9M
Asset Turnover	-	0.00x	0.01x	0.05x	0.12x	0.22x
Asset Growth %	-	1.34%	1.83%	-0.34%	-0.3%	-0.37%
Total Current Liabilities+	1.79M	4.12M	15.74M	8.8M	8.77M	8.73M
Accounts Payable	1.19M	948K	2.25M	678K	1.21M	1.61M
Days Payables Outstanding	-	448.79	308.12	41.89	70.62	83.81
Short-Term Debt	0	0	0	0	0	0
Deferred Revenue (Current)	0	0	730K	1000K	1000K	1000K
Other Current Liabilities	107K	1.79M	700K	2.2M	2.91M	473K
Current Ratio	15.63x	16.60x	12.55x	14.62x	10.14x	6.15x
Quick Ratio	15.63x	16.18x	12.28x	14.09x	9.39x	5.48x
Cash Conversion Cycle	-	580.55	439.75	411.37	448.92	455.5
Total Non-Current Liabilities+	0	178K	510K	1.53M	1.03M	1.13M
Long-Term Debt	0	178K	0	0	0	0
Capital Lease Obligations	0	0	0	0	0	0
Deferred Tax Liabilities	0	0	0	0	0	0
Other Non-Current Liabilities	0	1	0	0	64K	78K
Total Liabilities	1.79M	4.29M	16.25M	10.33M	9.8M	9.86M
Total Debt+	0	178K	0	0	185K	269K
Net Debt	-26.44M	-62.5M	-188.5M	-118.24M	-75M	-37.38M
Debt / Equity	-	0.00x	-	-	0.00x	0.01x
Debt / EBITDA	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-
Interest Coverage	-	-	-	-	-	-
Total Equity+	28.78M	67.23M	186.23M	123.72M	84.4M	49.04M
Equity Growth %	-	1.34%	1.77%	-0.34%	-0.32%	-0.42%
Book Value per Share	6.22	2.67	2.65	1.76	1.18	0.68
Total Shareholders' Equity	28.78M	67.23M	186.23M	123.72M	84.4M	49.04M
Common Stock	0	0	7K	7K	7K	7K
Retained Earnings	-48.04M	-71.47M	-136.32M	-209.48M	-253.72M	-294.44M
Treasury Stock	0	0	0	0	0	0
Accumulated OCI	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0

Cash Flow

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-18.37M	-21.52M	-47.18M	-72.34M	-41.81M	-38.77M
Operating CF Margin %	-	-73.21%	-31.54%	-10.62%	-3.79%	-3.01%
Operating CF Growth %	-	-0.17%	-1.19%	-0.53%	0.42%	0.07%
Net Income	-19.41M	-23.43M	-64.85M	-73.16M	-44.24M	-40.72M
Depreciation & Amortization	141K	289K	726K	1.01M	1.05M	1.01M
Stock-Based Compensation	896K	1.12M	6.9M	10.65M	4.74M	4.36M
Deferred Taxes	0	0	0	0	0	0
Other Non-Cash Items	4K	169K	1.07M	91K	249K	204K
Working Capital Changes	2K	327K	8.97M	-10.93M	-3.62M	-3.62M
Change in Receivables	309K	-956K	981K	-1.55M	-1.57M	-2.77M
Change in Inventory	-651K	-1.93M	-2.67M	-312K	-2.21M	562K
Change in Payables	467K	-377K	1.44M	-1.57M	533K	382K
Cash from Investing+	-244K	-1.57M	-2.71M	-585K	-804K	-383K
Capital Expenditures	-244K	-1.57M	-2.71M	-585K	-804K	-383K
CapEx % of Revenue	-	5.33%	1.81%	0.09%	0.07%	0.03%
Acquisitions	-	-	-	-	-	-
Investments	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0
Cash from Financing+	4.74M	60.94M	176.77M	7K	174K	1.02M
Debt Issued (Net)	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-
Other Financing	5.74M	991K	146.48M	0	0	171K
Net Change in Cash	-	-	-	-	-	-
Free Cash Flow+	-18.62M	-23.09M	-49.89M	-72.92M	-42.61M	-39.15M
FCF Margin %	-	-78.55%	-33.35%	-10.7%	-3.86%	-3.04%
FCF Growth %	-	-0.24%	-1.16%	-0.46%	0.42%	0.08%
FCF per Share	-4.03	-0.92	-0.71	-1.04	-0.60	-0.54
FCF Conversion (FCF/Net Income)	0.98x	0.92x	0.73x	0.99x	0.95x	0.95x
Interest Paid	0	6K	0	0	0	0
Taxes Paid	0	0	0	0	0	0

Key Ratios

Metric	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-65.27%	-48.65%	-51.16%	-47.21%	-42.51%	-61.03%
Return on Invested Capital (ROIC)	-	-498.04%	-3950.55%	-3454.21%	-485.03%	-307.79%
Gross Margin	-	-162.24%	-78.01%	13.31%	43.12%	45.7%
Net Margin	-	-7944.56%	-4333.76%	-1073.73%	-401%	-315.9%
Debt / Equity	-	0.00x	-	-	0.00x	0.01x
FCF Conversion	0.98x	0.92x	0.73x	0.99x	0.95x	0.95x
Revenue Growth	-	-	408.84%	355.48%	61.9%	16.84%

Revenue by Segment

	2021	2022	2023	2024
Product	-	-	8.75M	10.45M
Product Growth	-	-	-	19.48%
Service	-	-	2.29M	2.44M
Service Growth	-	-	-	6.74%

Revenue by Geography

	2021	2022	2023	2024
Non-US	-	2.54M	4.36M	6.39M
Non-US Growth	-	-	71.87%	46.58%
AUSTRALIA	78K	-	-	-
AUSTRALIA Growth	-	-	-	-

Frequently Asked Questions

Growth & Financials

Hyperfine, Inc. (HYPR) reported $10.6M in revenue for fiscal year 2024.

Hyperfine, Inc. (HYPR) grew revenue by 16.8% over the past year. This is strong growth.

Hyperfine, Inc. (HYPR) reported a net loss of $40.1M for fiscal year 2024.

Dividend & Returns

Hyperfine, Inc. (HYPR) has a return on equity (ROE) of -61.0%. Negative ROE indicates the company is unprofitable.

Hyperfine, Inc. (HYPR) had negative free cash flow of $32.2M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener